Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 2/20 | 0.65 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.65 |
| ▸ | SIGMAR1 | Q99720 | 8/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.37 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.37 |
| ▸ | PADI1 | Q9ULC6 | 1/20 | 0.37 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | METAP2 | P50579 | 1/20 | 0.35 |
| ▸ | METAP1 | P53582 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL255190 | 0.79 | CHRM5 (1.00) | CHRM5CHRM3SIGMAR1ALDH1A1NPC1 | |
| SCHEMBL11445619 | 0.77 | MEN1 (0.46) | CHRM5CHRM3SIGMAR1ALDH1A1PADI1 | |
| SCHEMBL2007992 | 0.75 | CHRM5 (0.67) | CHRM5CHRM3SIGMAR1ALDH1A1PADI1 | |
| Ethyl Piperazinoacetate SCHEMBL5699 | 0.74 | SIGMAR1 (0.49) | CHRM5CHRM3SIGMAR1ALDH1A1 | |
| SCHEMBL983664 | 0.74 | CHRM5 (0.71) | CHRM5CHRM3SIGMAR1ALDH1A1NPC1 | |
| Hydrochloric Acid SCHEMBL2008643 | 0.73 | CHRM5 (0.65) | CHRM5CHRM3SIGMAR1ALDH1A1PADI1 | |
| SCHEMBL16267250 | 0.73 | PADI1 (0.47) | CHRM5CHRM3SIGMAR1ALDH1A1PADI1 | |
| Ethyl Piperazinoacetate SCHEMBL17271810 | 0.73 | SIGMAR1 (0.47) | CHRM5CHRM3SIGMAR1ALDH1A1 | |
| SCHEMBL8911402 | 0.73 | SIGMAR1 (0.47) | CHRM5CHRM3SIGMAR1ALDH1A1 | |
| Ethyl Piperazinoacetate SCHEMBL16528281 | 0.73 | SIGMAR1 (0.47) | CHRM5CHRM3SIGMAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2391610-B1 | LUMINESCENT LANTHANIDE COMPLEXES | UNIV DURHAM (GB) | 2016-10-26 | — | — | EP | disclosed |
| US-9448225-B2 | Responsive luminescent lathanide complexes | UNIVERSITY OF DURHAM (GB) | 2016-09-20 | — | — | US | disclosed |
| US-20140179015-A1 | RESPONSIVE LUMINESCENT LATHANIDE COMPLEXES | UNIVERSITY OF DURHAM (GB) | 2014-06-26 | — | — | US | disclosed |
| US-8628978-B2 | Responsive luminescent lanthanide complexes | UNIVERSITY OF DURHAM (GB) | 2014-01-14 | — | — | US | disclosed |
| US-20110287558-A1 | RESPONSIVE LUMINESCENT LANTHANIDE COMPLEXES | UNIVERSITY OF DURHAM (GB) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179015-A1 | RESPONSIVE LUMINESCENT LATHANIDE COMPLEXES | GLRX3, SUCNR1, SDHA | CHRM5 1428/4885CHRM3 1917/4885SIGMAR1 2556/4885 |
| US-20110287558-A1 | RESPONSIVE LUMINESCENT LANTHANIDE COMPLEXES | GLRX3, SDHA, SUCNR1 | CHRM5 1371/4885CHRM3 1768/4885SIGMAR1 2798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.